0001209191-20-065414.txt : 20201229
0001209191-20-065414.hdr.sgml : 20201229
20201229185835
ACCESSION NUMBER: 0001209191-20-065414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201224
FILED AS OF DATE: 20201229
DATE AS OF CHANGE: 20201229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Thomas A.
CENTRAL INDEX KEY: 0001648283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 201423668
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-24
0
0001340652
ChemoCentryx, Inc.
CCXI
0001648283
Edwards Thomas A.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2020-12-24
4
S
0
14218
61.1833
D
152139
D
Common Stock
2020-12-28
4
S
0
10782
61.50
D
141357
D
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $61.09 to $61.41 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2020-12-29